Published in Arch Gen Psychiatry on November 01, 1999
Brain structural and functional abnormalities in mood disorders: implications for neurocircuitry models of depression. Brain Struct Funct (2008) 6.32
Neurocircuitry of mood disorders. Neuropsychopharmacology (2010) 5.57
Social supports and serotonin transporter gene moderate depression in maltreated children. Proc Natl Acad Sci U S A (2004) 4.42
Evolving knowledge of sex differences in brain structure, function, and chemistry. Biol Psychiatry (2007) 3.02
The stressed synapse: the impact of stress and glucocorticoids on glutamate transmission. Nat Rev Neurosci (2011) 2.82
Individual differences in subconscious motor control predicted by GABA concentration in SMA. Curr Biol (2010) 2.21
In vivo magnetic resonance spectroscopy of GABA: a methodological review. Prog Nucl Magn Reson Spectrosc (2011) 1.91
The GABAergic deficit hypothesis of major depressive disorder. Mol Psychiatry (2010) 1.80
GABAergic neurons immunoreactive for calcium binding proteins are reduced in the prefrontal cortex in major depression. Neuropsychopharmacology (2006) 1.80
Enhanced visual motion perception in major depressive disorder. J Neurosci (2009) 1.71
Patient classification as an outlier detection problem: an application of the One-Class Support Vector Machine. Neuroimage (2011) 1.69
Acute shift in glutamate concentrations following experimentally induced panic with cholecystokinin tetrapeptide--a 3T-MRS study in healthy subjects. Neuropsychopharmacology (2013) 1.67
Molecular evidence for BDNF- and GABA-related dysfunctions in the amygdala of female subjects with major depression. Mol Psychiatry (2011) 1.48
Glutamate-modulating drugs as novel pharmacotherapeutic agents in the treatment of obsessive-compulsive disorder. NeuroRx (2006) 1.43
Amino acid neurotransmitters assessed by proton magnetic resonance spectroscopy: relationship to treatment resistance in major depressive disorder. Biol Psychiatry (2008) 1.42
GABA-related transcripts in the dorsolateral prefrontal cortex in mood disorders. Int J Neuropsychopharmacol (2011) 1.38
In vivo detection of GABA and glutamate with MEGA-PRESS: reproducibility and gender effects. J Magn Reson Imaging (2011) 1.36
Sex, GABA, and nicotine: the impact of smoking on cortical GABA levels across the menstrual cycle as measured with proton magnetic resonance spectroscopy. Biol Psychiatry (2005) 1.33
The future of ultra-high field MRI and fMRI for study of the human brain. Neuroimage (2011) 1.33
Dorsolateral prefrontal γ-aminobutyric acid in men predicts individual differences in rash impulsivity. Biol Psychiatry (2011) 1.31
Gene expression profiling in postmortem prefrontal cortex of major depressive disorder. J Neurosci (2007) 1.30
Pharmacogenetics of antidepressant response. J Psychiatry Neurosci (2011) 1.28
Stress impairs GABAergic network function in the hippocampus by activating nongenomic glucocorticoid receptors and affecting the integrity of the parvalbumin-expressing neuronal network. Neuropsychopharmacology (2010) 1.27
Anterior cingulate cortex γ-aminobutyric acid in depressed adolescents: relationship to anhedonia. Arch Gen Psychiatry (2011) 1.23
Glutamate receptor antagonists as fast-acting therapeutic alternatives for the treatment of depression: ketamine and other compounds. Annu Rev Pharmacol Toxicol (2014) 1.21
GABAA receptor subtypes: Therapeutic potential in Down syndrome, affective disorders, schizophrenia, and autism. Annu Rev Pharmacol Toxicol (2013) 1.20
Reduced brain GABA in primary insomnia: preliminary data from 4T proton magnetic resonance spectroscopy (1H-MRS). Sleep (2008) 1.18
The effects of repetitive transcranial magnetic stimulation on cortical inhibition in healthy human subjects. Exp Brain Res (2006) 1.15
Acute mania is accompanied by elevated glutamate/glutamine levels within the left dorsolateral prefrontal cortex. Psychopharmacology (Berl) (2003) 1.15
Reduced somatostatin in subgenual anterior cingulate cortex in major depression. Neurobiol Dis (2011) 1.13
Innovative approaches for the development of antidepressant drugs: current and future strategies. NeuroRx (2005) 1.10
Sexually dimorphic expression of KCC2 and GABA function. Epilepsy Res (2008) 1.10
Reduced density of calbindin immunoreactive GABAergic neurons in the occipital cortex in major depression: relevance to neuroimaging studies. Biol Psychiatry (2009) 1.10
Edited magnetic resonance spectroscopy detects an age-related decline in brain GABA levels. Neuroimage (2013) 1.06
Preliminary evidence of reduced occipital GABA concentrations in puerperal women: a 1H-MRS study. Psychopharmacology (Berl) (2006) 1.06
Reduced level of glutamic acid decarboxylase-67 kDa in the prefrontal cortex in major depression. Int J Neuropsychopharmacol (2009) 1.05
Accuracy and stability of measuring GABA, glutamate, and glutamine by proton magnetic resonance spectroscopy: a phantom study at 4 Tesla. J Magn Reson (2010) 1.04
Investigation of cortical glutamate-glutamine and γ-aminobutyric acid in obsessive-compulsive disorder by proton magnetic resonance spectroscopy. Neuropsychopharmacology (2012) 1.04
The impact of gabapentin administration on brain GABA and glutamate concentrations: a 7T ¹H-MRS study. Neuropsychopharmacology (2012) 1.03
Elevated levels of NR2A and PSD-95 in the lateral amygdala in depression. Int J Neuropsychopharmacol (2008) 1.03
Research applications of magnetic resonance spectroscopy to investigate psychiatric disorders. Top Magn Reson Imaging (2008) 1.03
Prefrontal cortical gamma-aminobutyric Acid levels in panic disorder determined by proton magnetic resonance spectroscopy. Biol Psychiatry (2008) 1.03
Genetic modulation of GABA levels in the anterior cingulate cortex by GAD1 and COMT. Neuropsychopharmacology (2010) 1.02
Reduced γ-aminobutyric acid in occipital and anterior cingulate cortices in primary insomnia: a link to major depressive disorder? Neuropsychopharmacology (2012) 0.99
Opposing effects of acute versus chronic blockade of frontal cortex somatostatin-positive inhibitory neurons on behavioral emotionality in mice. Neuropsychopharmacology (2014) 0.96
Interactions between age, sex, and hormones in experimental ischemic stroke. Neurochem Int (2012) 0.96
Assortment of GABAergic plasticity in the cortical interneuron melting pot. Neural Plast (2011) 0.95
The Role of Genetic Sex in Affect Regulation and Expression of GABA-Related Genes Across Species. Front Psychiatry (2013) 0.95
Disruption of fetal hormonal programming (prenatal stress) implicates shared risk for sex differences in depression and cardiovascular disease. Front Neuroendocrinol (2013) 0.93
Clinical application of brain imaging for the diagnosis of mood disorders: the current state of play. Mol Psychiatry (2013) 0.93
Developmental influence of the serotonin transporter on the expression of npas4 and GABAergic markers: modulation by antidepressant treatment. Neuropsychopharmacology (2011) 0.92
Cortical GABA levels in primary insomnia. Sleep (2012) 0.92
Neuroplasticity in depressed individuals compared with healthy controls. Neuropsychopharmacology (2013) 0.92
Simultaneous detection of resolved glutamate, glutamine, and gamma-aminobutyric acid at 4 T. J Magn Reson (2006) 0.92
Antidepressant-like activity of CGP 36742 and CGP 51176, selective GABAB receptor antagonists, in rodents. Br J Pharmacol (2006) 0.90
Expression profiling of a genetic animal model of depression reveals novel molecular pathways underlying depressive-like behaviours. PLoS One (2010) 0.90
Advances in the treatment of anxiety: targeting glutamate. NeuroRx (2006) 0.90
A pilot in vivo proton magnetic resonance spectroscopy study of amino acid neurotransmitter response to ketamine treatment of major depressive disorder. Mol Psychiatry (2015) 0.90
Reduced parahippocampal and lateral temporal GABAA-[11C]flumazenil binding in major depression: preliminary results. Eur J Nucl Med Mol Imaging (2009) 0.90
Cortical gamma-aminobutyric acid and glutamate in posttraumatic stress disorder and their relationships to self-reported sleep quality. Sleep (2014) 0.89
Glutamate and choline levels predict individual differences in reading ability in emergent readers. J Neurosci (2014) 0.89
Altered functional connectivity density in major depressive disorder at rest. Eur Arch Psychiatry Clin Neurosci (2015) 0.89
Review: magnetic resonance spectroscopy studies of pediatric major depressive disorder. Depress Res Treat (2010) 0.89
Depressive-like behavior in adolescents after maternal separation: sex differences, controllability, and GABA. Dev Neurosci (2012) 0.88
Prefrontal GABA levels in cocaine-dependent subjects increase with pramipexole and venlafaxine treatment. Psychopharmacology (Berl) (2005) 0.88
The relevance of neuroactive steroids in schizophrenia, depression, and anxiety disorders. Cell Mol Neurobiol (2007) 0.87
Increased glutamate levels in the medial prefrontal cortex in patients with postpartum depression. Neuropsychopharmacology (2012) 0.87
Multi-regional investigation of the relationship between functional MRI blood oxygenation level dependent (BOLD) activation and GABA concentration. PLoS One (2015) 0.87
The role of GABA in primary insomnia. Sleep (2012) 0.86
Quantitative trait locus analysis identifies Gabra3 as a regulator of behavioral despair in mice. Mamm Genome (2010) 0.86
Bidirectional Homeostatic Regulation of a Depression-Related Brain State by Gamma-Aminobutyric Acidergic Deficits and Ketamine Treatment. Biol Psychiatry (2016) 0.86
GABAergic control of depression-related brain states. Adv Pharmacol (2015) 0.86
Regional difference in GABA levels between medial prefrontal and occipital cortices. J Magn Reson Imaging (2013) 0.85
In vivo neurochemistry of primary focal hand dystonia: a magnetic resonance spectroscopic neurometabolite profiling study at 3T. Mov Disord (2010) 0.85
Biomarkers of epileptogenesis: psychiatric comorbidities (?). Neurotherapeutics (2014) 0.85
Sex differences in mood disorders: perspectives from humans and rodent models. Biol Sex Differ (2014) 0.84
Neurochemistry of major depression: a study using magnetic resonance spectroscopy. Psychopharmacology (Berl) (2014) 0.84
Twenty-one-base-pair insertion polymorphism creates an enhancer element and potentiates SLC6A1 GABA transporter promoter activity. Pharmacogenet Genomics (2009) 0.84
Pathophysiology of depression and mechanisms of treatment. Dialogues Clin Neurosci (2002) 0.84
Anxiety in major depression and cerebrospinal fluid free gamma-aminobutyric acid. Depress Anxiety (2014) 0.84
Maternal immune activation leads to selective functional deficits in offspring parvalbumin interneurons. Mol Psychiatry (2016) 0.84
Increased occipital delta dipole density in major depressive disorder determined by magnetoencephalography. J Psychiatry Neurosci (2005) 0.83
Sex chromosome complement regulates expression of mood-related genes. Biol Sex Differ (2013) 0.83
Altered γ-aminobutyric acid neurotransmission in major depressive disorder: a critical review of the supporting evidence and the influence of serotonergic antidepressants. Drug Des Devel Ther (2015) 0.83
Magnetic resonance spectroscopy in the evaluation of treatment efficacy in unipolar major depressive disorder: a review of the literature. Funct Neurol (2012) 0.83
Cognitive functions of regularly cycling women may differ throughout the month, depending on sex hormone status; a possible explanation to conflicting results of studies of ADHD in females. Front Hum Neurosci (2014) 0.82
GABAA receptor-acting neurosteroids: a role in the development and regulation of the stress response. Front Neuroendocrinol (2014) 0.82
Risk of psychiatric disorders following trigeminal neuralgia: a nationwide population-based retrospective cohort study. J Headache Pain (2015) 0.82
Defects in dendrite and spine maturation and synaptogenesis associated with an anxious-depressive-like phenotype of GABAA receptor-deficient mice. Neuropharmacology (2014) 0.81
Elevated endogenous GABA concentration attenuates glutamate-glutamine cycling between neurons and astroglia. J Neural Transm (Vienna) (2009) 0.81
Disinhibition of somatostatin-positive GABAergic interneurons results in an anxiolytic and antidepressant-like brain state. Mol Psychiatry (2016) 0.81
Decreased occipital cortical glutamate levels in response to successful cognitive-behavioral therapy and pharmacotherapy for major depressive disorder. Psychother Psychosom (2014) 0.81
Future prospects in depression research. Dialogues Clin Neurosci (2006) 0.81
Frontal Gamma-Aminobutyric Acid Concentrations Are Associated With Cognitive Performance in Older Adults. Biol Psychiatry Cogn Neurosci Neuroimaging (2017) 0.80
Repeated administration of imipramine modifies GABAergic transmission in rat frontal cortex. J Neural Transm (Vienna) (2012) 0.79
Proton magnetic resonance spectroscopy in depression. Indian J Psychiatry (2011) 0.79
Fgfr1 inactivation in the mouse telencephalon results in impaired maturation of interneurons expressing parvalbumin. PLoS One (2014) 0.79
Deletion of mouse FXR gene disturbs multiple neurotransmitter systems and alters neurobehavior. Front Behav Neurosci (2015) 0.79
Normal [3H]flunitrazepam binding to GABAA receptors in the locus coeruleus in major depression and suicide. Brain Res (2006) 0.79
The development of a Clinician-Administered PTSD Scale. J Trauma Stress (1995) 22.71
The Yale-Brown Obsessive Compulsive Scale. I. Development, use, and reliability. Arch Gen Psychiatry (1989) 16.61
Antidepressant effects of ketamine in depressed patients. Biol Psychiatry (2000) 10.91
Subanesthetic effects of the noncompetitive NMDA antagonist, ketamine, in humans. Psychotomimetic, perceptual, cognitive, and neuroendocrine responses. Arch Gen Psychiatry (1994) 8.88
Impaired glucose transport as a cause of decreased insulin-stimulated muscle glycogen synthesis in type 2 diabetes. N Engl J Med (1999) 8.32
Intramyocellular lipid concentrations are correlated with insulin sensitivity in humans: a 1H NMR spectroscopy study. Diabetologia (1999) 8.17
Quantitation of muscle glycogen synthesis in normal subjects and subjects with non-insulin-dependent diabetes by 13C nuclear magnetic resonance spectroscopy. N Engl J Med (1990) 7.13
The Yale-Brown Obsessive Compulsive Scale. II. Validity. Arch Gen Psychiatry (1989) 6.80
Effects of free fatty acids on glucose transport and IRS-1-associated phosphatidylinositol 3-kinase activity. J Clin Invest (1999) 6.73
Mechanism of free fatty acid-induced insulin resistance in humans. J Clin Invest (1996) 6.50
MRI-based measurement of hippocampal volume in patients with combat-related posttraumatic stress disorder. Am J Psychiatry (1995) 5.34
Consistency of memory for combat-related traumatic events in veterans of Operation Desert Storm. Am J Psychiatry (1997) 5.13
Hippocampal volume reduction in major depression. Am J Psychiatry (2000) 5.04
Energy on demand. Science (1999) 3.80
Serotonin function and the mechanism of antidepressant action. Reversal of antidepressant-induced remission by rapid depletion of plasma tryptophan. Arch Gen Psychiatry (1990) 3.57
Increased rate of gluconeogenesis in type II diabetes mellitus. A 13C nuclear magnetic resonance study. J Clin Invest (1992) 3.55
Magnetic resonance imaging-based measurement of hippocampal volume in posttraumatic stress disorder related to childhood physical and sexual abuse--a preliminary report. Biol Psychiatry (1997) 3.39
Single photon emission computerized tomography imaging of amphetamine-induced dopamine release in drug-free schizophrenic subjects. Proc Natl Acad Sci U S A (1996) 3.28
The cellular neurobiology of depression. Nat Med (2001) 3.19
Stoichiometric coupling of brain glucose metabolism and glutamatergic neuronal activity. Proc Natl Acad Sci U S A (1998) 3.17
Measurement of dissociative states with the Clinician-Administered Dissociative States Scale (CADSS). J Trauma Stress (1998) 3.07
Glutamate and GABA systems as targets for novel antidepressant and mood-stabilizing treatments. Mol Psychiatry (2002) 3.01
Attenuation of the neuropsychiatric effects of ketamine with lamotrigine: support for hyperglutamatergic effects of N-methyl-D-aspartate receptor antagonists. Arch Gen Psychiatry (2000) 2.92
Increased glucose transport-phosphorylation and muscle glycogen synthesis after exercise training in insulin-resistant subjects. N Engl J Med (1996) 2.92
Abnormal noradrenergic function in posttraumatic stress disorder. Arch Gen Psychiatry (1993) 2.89
Localized 1H NMR measurements of gamma-aminobutyric acid in human brain in vivo. Proc Natl Acad Sci U S A (1993) 2.77
Determination of the rate of the glutamate/glutamine cycle in the human brain by in vivo 13C NMR. Proc Natl Acad Sci U S A (1999) 2.76
Effect of triiodothyronine on mitochondrial energy coupling in human skeletal muscle. J Clin Invest (2001) 2.68
Neural correlates of exposure to traumatic pictures and sound in Vietnam combat veterans with and without posttraumatic stress disorder: a positron emission tomography study. Biol Psychiatry (1999) 2.62
A neurobiological basis for substance abuse comorbidity in schizophrenia. Biol Psychiatry (2001) 2.58
Spatially localized 1H NMR spectra of metabolites in the human brain. Proc Natl Acad Sci U S A (1988) 2.44
Glial pathology in an animal model of depression: reversal of stress-induced cellular, metabolic and behavioral deficits by the glutamate-modulating drug riluzole. Mol Psychiatry (2008) 2.42
High-resolution 1H nuclear magnetic resonance study of cerebral hypoxia in vivo. Proc Natl Acad Sci U S A (1983) 2.40
Analysis of macromolecule resonances in 1H NMR spectra of human brain. Magn Reson Med (1994) 2.39
Neural correlates of memories of childhood sexual abuse in women with and without posttraumatic stress disorder. Am J Psychiatry (1999) 2.35
Increased striatal dopamine transmission in schizophrenia: confirmation in a second cohort. Am J Psychiatry (1998) 2.30
Effects of early adverse experiences on brain structure and function: clinical implications. Biol Psychiatry (2000) 2.27
Elevated CSF corticotropin-releasing factor concentrations in posttraumatic stress disorder. Am J Psychiatry (1997) 2.22
13C/31P NMR studies on the mechanism of insulin resistance in obesity. Diabetes (1998) 2.21
Clinical phenomenology and neurobiology of cocaine abstinence: a prospective inpatient study. Am J Psychiatry (1991) 2.17
Childhood physical abuse and combat-related posttraumatic stress disorder in Vietnam veterans. Am J Psychiatry (1993) 2.16
In vivo 13C NMR measurements of cerebral glutamine synthesis as evidence for glutamate-glutamine cycling. Proc Natl Acad Sci U S A (1997) 2.12
Neuroendocrine and behavioral responses to intravenous m-chlorophenylpiperazine (mCPP) in depressed patients and healthy comparison subjects. Am J Psychiatry (1994) 2.04
Report of the Institute of Medicine Committee on the Efficacy and Safety of Halcion. Arch Gen Psychiatry (1999) 2.03
Reduced brain serotonin transporter availability in major depression as measured by [123I]-2 beta-carbomethoxy-3 beta-(4-iodophenyl)tropane and single photon emission computed tomography. Biol Psychiatry (1998) 2.03
Dose-related ethanol-like effects of the NMDA antagonist, ketamine, in recently detoxified alcoholics. Arch Gen Psychiatry (1998) 2.02
Simultaneous determination of the rates of the TCA cycle, glucose utilization, alpha-ketoglutarate/glutamate exchange, and glutamine synthesis in human brain by NMR. J Cereb Blood Flow Metab (1995) 1.98
Role of norepinephrine in the pathophysiology and treatment of posttraumatic stress disorder. Biol Psychiatry (1999) 1.97
Noradrenergic mechanisms in stress and anxiety: I. Preclinical studies. Synapse (1996) 1.97
Dynamic mapping of the human visual cortex by high-speed magnetic resonance imaging. Proc Natl Acad Sci U S A (1992) 1.92
Improvements on an in vivo automatic shimming method [FASTERMAP]. Magn Reson Med (1997) 1.92
NMR determination of the TCA cycle rate and alpha-ketoglutarate/glutamate exchange rate in rat brain. J Cereb Blood Flow Metab (1992) 1.89
Psychobiologic mechanisms of posttraumatic stress disorder. Arch Gen Psychiatry (1993) 1.88
Chronic PTSD in Vietnam combat veterans: course of illness and substance abuse. Am J Psychiatry (1996) 1.87
Neuroendocrine and mood responses to intravenous L-tryptophan in 3,4-methylenedioxymethamphetamine (MDMA) users. Preliminary observations. Arch Gen Psychiatry (1989) 1.86
Activation of human prefrontal cortex during spatial and nonspatial working memory tasks measured by functional MRI. Cereb Cortex (1996) 1.82
Deficits in short-term memory in posttraumatic stress disorder. Am J Psychiatry (1993) 1.81
Functional magnetic resonance imaging of human prefrontal cortex activation during a spatial working memory task. Proc Natl Acad Sci U S A (1994) 1.79
Age-related decline in striatal dopamine transporter binding with iodine-123-beta-CITSPECT. J Nucl Med (1995) 1.77
Homonuclear 1H double-resonance difference spectroscopy of the rat brain in vivo. Proc Natl Acad Sci U S A (1984) 1.76
Mechanism by which glucose and insulin inhibit net hepatic glycogenolysis in humans. J Clin Invest (1998) 1.75
Noradrenergic mechanisms in stress and anxiety: II. Clinical studies. Synapse (1996) 1.75
Cerebral energetics and the glycogen shunt: neurochemical basis of functional imaging. Proc Natl Acad Sci U S A (2001) 1.74
Increased tricarboxylic acid cycle flux in rat brain during forepaw stimulation detected with 1H[13C]NMR. Proc Natl Acad Sci U S A (1996) 1.74
The flux from glucose to glutamate in the rat brain in vivo as determined by 1H-observed, 13C-edited NMR spectroscopy. J Cereb Blood Flow Metab (1990) 1.74
13C NMR study of transamination during acetate utilization by Saccharomyces cerevisiae. Proc Natl Acad Sci U S A (1981) 1.70
Decreased single-photon emission computed tomographic [123I]beta-CIT striatal uptake correlates with symptom severity in Parkinson's disease. Ann Neurol (1995) 1.70
Toward a neurobiology of delusions. Prog Neurobiol (2010) 1.70
Cerebral metabolic studies in vivo by 31P NMR. Proc Natl Acad Sci U S A (1983) 1.69
Quantitative functional imaging of the brain: towards mapping neuronal activity by BOLD fMRI. NMR Biomed (2001) 1.69
Quantitative 1H spectroscopic imaging of human brain at 4.1 T using image segmentation. Magn Reson Med (1996) 1.67